Get started
Author

Aminda De Silva

Observed names: A. D. Silva, Aminda De Silva, Aminda de Silva, Dr. Aminda De Silva
ORCID: 0000-0002-0745-5564
Observed ORCID: 0000-0002-0745-5564
OpenAlex ID: A5005234168
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
2023 · Christina Kapizioni, Rofaida Desoki, et al. · Journal of Crohn s and Colitis · 154
PDF
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
2021 · Laurent Peyrin-Biroulet, Ailsa Hart, et al. · The Lancet. Gastroenterology & hepatology · 103
PDF
A review on the use of prebiotics in ulcerative colitis
2023 · James M. Kennedy, Aminda De Silva, et al. · Trends in Microbiology · 60
Refeeding syndrome : physiological background and practical management
2019 · Aminda De Silva, Jeremy M D Nightingale · Frontline Gastroenterology · 51
Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy ( IMSAT ) therapeutic drug monitoring study
2022 · Neil Chanchlani, Simeng Lin, et al. · Alimentary Pharmacology & Therapeutics · 22
PDF
Supporting people who have eating and drinking difficulties
2021 · Karen Porter, Nicola Burch, et al. · Clinical Medicine · 21
PDF
Attitudes to NICE guidance on refeeding syndrome
2008 · A. D. Silva, T. Smith, et al. · BMJ · 20
Tight glucose control in intensive care units: an update with an emphasis on nutritional issues
2008 · Marinos Elia, Aminda De Silva · Current Opinion in Clinical Nutrition & Metabolic Care · 16
Comparison of prebiotic candidates in ulcerative colitis using an in vitro fermentation model
2024 · James M Kennedy, Aminda De Silva, et al. · Journal of Applied Microbiology · 15
PDF
Pyoderma gangrenosum as a first presentation of inflammatory bowel disease
2014 · Shahana Shahid, Margaret Myszor, et al. · BMJ Case Reports · 14
PDF
Refeeding risks in patients requiring intravenous nutrition support: Results of a two-centre, prospective, double-blind, randomised controlled trial
2021 · Tim Ambrose, Aminda De Silva, et al. · Clinical Nutrition ESPEN · 11
Steroids in inflammatory bowel disease: a clinical review
2021 · Arif Hussenbux, Aminda De Silva · Journal of Prescribing Practice · 10
HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype–phenotype association study
2026 · Qian Zhang, Eathar Shakweh, et al. · The Lancet. Gastroenterology & hepatology · 7
Metabolic acidosis in short bowel syndrome: think D-lactic acid acidosis
2018 · Sorin Stanciu, Aminda De Silva · BMJ Case Reports · 7
Efficacy of nasal bridles in avoiding percutaneous endoscopic gastrostomy placement
2012 · Gwilym Webb, Prakash Gupta, et al. · Frontline Gastroenterology · 7
Obesity: a window of opportunity to intervene? Characteristics and management of morbidly obese adult inpatients in three trusts in southern England
2013 · Tim Ambrose, Sue Cullen, et al. · Clinical Medicine · 5
PDF
Steroids in inflammatory bowel disease: a clinical review
2021 · Arif Hussenbux, Aminda De Silva · Gastrointestinal Nursing · 4
Management of psoriasis in patients treated with anti-TNF-α therapy for inflammatory bowel disease
2013 · Sujata Biswas, Margaret Myszor, et al. · Journal of Crohn s and Colitis · 2
Evaluation of accuracy of nutritional assessments using Malnutrition Universal Screening Tool (MUST) upon admission to the parenteral nutrition trained wards in one of the home parenteral nutrition centers
2024 · Dr Sugath Peiris, Ms. Joanne Wakeling, et al. · Clinical Nutrition ESPEN · 1
Medical management of eating disorders
2023 · Pete Turner, Aminda De Silva · Medicine · 1
P127 Real world effectiveness of ustekinumab for refractory Crohn’s disease: a regional experience
2021 · Colleen Mcgregor, Adib Tarafdar, et al. · Gut · 1
PDF
The Importance of Full-Thickness Jejunal Biopsy in Diagnosing Inflammatory Neuromuscular Gastrointestinal Disorders
2012 · Tim Ambrose, Fawaz Musa, et al. · The American Journal of Gastroenterology · 1
FP9 2'-fucosyllactose modulates gut microbiota and metabolic profiles in ulcerative colitist
2026 · James Kennedy, Patricia Sanz Morales, et al. · Gut
PDF
P419 Patients with intestinal methanogen overgrowth are frequently missed by hydrogen-only breath testing
2026 · James Kennedy, Megha Sahare, et al. · Gut
P202 Patient-reported disease control in a randomised crossover trial of 2′-fucosyllactose in mild-to-moderate ulcerative colitis
2026 · James Kennedy, Patricia Sanz Morales, et al. · Gut
Works count: 31
Citation count: 533
H-index: 11
I10-index: 12
Year
Topic
Type